This review seeks to establish, through the recent available literature, the prevalence of
therapeutic intensification delay and its sequences in poorly controlled Type 2 Diabetes …

Background Good-quality evidence has shown that early glycaemic, blood pressure and
LDL-cholesterol control in people with type 2 diabetes (T2D) leads to better outcomes. In …

Abstract Treatment intensification is essential to ensure guideline targets are attained in
diabetes patients. The failure to intensify treatment when the targets are not achieved is …

Aim Given a lack of data on diabetes care performance in Malaysia, we conducted a cross-
sectional study to understand the clinical characteristics, control of cardiometabolic risk …

Abstract Abstract Health systems in Latin America face many challenges in controlling the
increasing burden of diabetes. Digital health interventions are a promise for the provision of …

Background This study aimed to describe changes in body mass index, glycosylated
hemoglobin A1C, blood pressure, and low‐density lipoprotein (LDL)‐cholesterol among …

Concurrent attainment of glycated haemoglobin A1C, blood pressure, and LDL-cholesterol
goals, or collectively known as the 'ABC'goals, help prevent cardiovascular complications in …

Good control of glycosylated haemoglobin A1C in diabetes patients prevents cardiovascular
complications. We aim to describe the A1C trend and determine the predictors of the trend …

Abstract Aims The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) trial
tested a collaborative care model including electronic clinical decision support (CDS) for …

Background Type 2 diabetes mellitus (T2DM) patients with coronary artery disease (CAD)
have an increased risk of recurrent cardiovascular events. These patients require optimal …